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معدل إجراء فحص التحري الظريف للطخة بابا نيكوال 
بابا نيكوال عند النساء املراجعات يف مستشفى تعليمي و منط الشذوذ يف اخَلالَيا الِظهارِيَّة يف لطخات 
يف عجمان، اإلمارات العربية املتحدة
غيث ج العيد، رزوانة �صيخ
امللخ�ص: الهدف: تقدير نسبة النساء اخلاضعات لفحص لطخة بابا نيكوال وتواتر الشذوذ يف اخَلالَيا الِظهارِيَّة يف لطخات عنق الرحم يف مستشفى تعليمي 
يف عجمان بدولة اإلمارات العربية املتحدة خالل مدة زمنية معينة. الطريقة: دراسة استعادية لسجالت 602 مريضة خالل املدة من يوليو 2007 اىل يوليو 
2010 يف مستشفى تعليمي يف إمارة عجمان، اإلمارات العربية املتحدة. املتغريات اليت متت دراستها تشمل العمر والعرق وحالة انقطاع الطمث، وشذوذ 
لطخات بابا نيكوال. مت حتليل البيانات بواسطة برنامج اس يب اس اس – 19 ، ومت تقدمي البيانات بشكل نسب مئوية غالبا، كما استخدم اختبار مربع كاي 
لفحص مدى الرتابط النتائج: كان العدد الكلي للمريضات املراجعات لقسم األمراض النسائية والوالدات للفرتة من يوليو 2007 اىل يوليو 2010 هو 
150,111 مريضة، خضعت 602 منهن فقط )0.4%( من اجملموع الكلي( لفحص لطخة بابا نيكوال لعنق الرحم. شّكلت النساء العربيات % 50.1من 
العينة، والبقية من جنسيات آسيوية أخرى. كان لدى 73% من املريضات شكاوى مرضية معينة، بينما كان 72% منهن يف زيارة روتينية للمستشفى إلجراء 
فحص مسح عنق الرحم. تبني أن 3.3 % من املريضات كّن يعانني من شذوذ يف اخلاليا الظهارية لعنق الرحم كما يلي: 1.8% خاليا حرشفية ال منطية غري 
حمددة األمهية، 1.2% آفة اخلاليا الظهارية احلرشفية منخفضة الدرجة، 0.3% آفة اخلاليا الظهارية احلرشفية عالية الدرجة. مل تكن هناك اي من حاالت 
سرطان اخلاليا احلرشفية. اخلال�صة: كان املسح الطوعي الروتيين بواسطة لطخة بابا نيكوال منخفضا جدا عند املريضات يف هذه الدراسة، وشكلت آفة اخلاليا 
احلرشفية الال منطية غري حمددة األمهية األكثر تشخيصا ضمن شذوذ اخلاليا الظهارية. ننصح بتعزيز التثقيف الصحي يف اجملتمع وإجراء املسح الظريف لسرطان 
عنق الرحم لكل النساء يف املنطقة، سواء كّن من املواطنات أو الوافدات.
مفتاح الكلمات: لطخة بابا نيكوال، �رصطان عنق الرحم، التحري عن ال�رصطان، االإمارات العربية املتحدة.
abstract: Objectives: The aim of this study was to estimate the proportion of women undergoing Papanicolaou 
(Pap) smear examinations, and the frequency of epithelial cell abnormalities in a teaching hospital in one emirate 
of the United Arab Emirates (UAE) during a three-year period. Methods: A retrospective study of 602 patient 
records from July 2007 to July 2010 was done in a teaching hospital in Ajman, UAE. The variables studied were 
age, ethnicity, menopausal status, and abnormalities in the Pap smear. Data were analysed using the Statistical 
Package for the Social Sciences and presented mainly as percentages; to assess associations, the chi-square test 
was used. Results: The total number of outpatients who attended the Obstetrics & Gynaecology Department from 
July 2007 to July 2010 was 150,111 patients, of which 602 (0.4% of the total) had a Pap smear test. The sample was 
50.1% Arabs and 49.9% other nationalities. While 73% of the outpatients had specific complaints, 27% came for a 
routine screening. Epithelial cell abnormalities were seen in 3.3% of the sample, with atypical squamous cells of 
undetermined significance (ASCUS) found in 1.8%, low-grade squamous intraepithelial lesions (LSILs) found in 
1.2%, and high-grade squamous intraepithelial lesions (HSILs) found in 0.3%. There were no cases of squamous cell 
carcinoma. Conclusion: Voluntary routine Pap smear screening was remarkably low in the study group. ASCUS 
was the most common epithelial cell abnormality. Community health education and opportunistic screening for 
cervical cancer are recommended for both national and expatriate women in the region. 
Keywords: Papanicolaou smear; Cervix cancer; Cancer screening; United Arab Emirates. 
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Cervical cancer is the second most common cancer in women worldwide, with about 500,000 new cases and 250,000 
deaths each year.1 Globally, it is estimated that over 
one million women currently have cervical cancer, 
most of whom have not been diagnosed, or have no 
access to treatment that could cure them or prolong 
their lives.2 Cervical cancer is the third most 
common cancer in women—both in citizens and 
non-citizens—in the United Arab Emirates (UAE).3 
Screening for cervical cancer is not mandatory in 
the UAE. 
Secondary prevention of cervical cancer 
goes beyond the laboratory test. It calls for the 
establishment of a comprehensive screening 
programme targeting appropriate age groups. 
This helps to identify asymptomatic women with 
precursor lesions of cervical cancer as well as to 
create effective links between all levels of care, 
including appropriate follow-up for definitive 
diagnosis and the treatment of women with positive 
screening results.2
Cervicovaginal cytology screening with 
Papanicolau (Pap) smears has been used in many 
regions of the world since the last century. Dr. 
Papanicolau, the innovator of Pap smear testing, 
emphasised the need for a simple inexpensive 
method that could be applied on a large scale for 
the early diagnosis of cancer. This test is crucial 
for the detection of early changes like dysplasia 
in the cervical cells which lead to cancer. Over 
time, cervical dysplasia can gradually develop into 
squamous cell carcinoma of the cervix.2
In developed countries where cervical screening 
programmes are implemented and encouraged, 
new cases are not as advanced as those in 
developing countries.4 One possible explanation is 
that in countries with no screening programmes, 
women usually present to the clinic only when they 
have symptoms, such as pain, discharge, and/or 
abnormal bleeding. Cervical cancer, being a slow-
growing cancer, can take up to 10 and sometimes 20 
years for abnormal changes to develop into cancer.5 
For this reason, cervical cancer is more frequent in 
women in their fourth, fifth or sixth decade of life.6,7 
Cervical screening can help save lives, and that is 
why many countries are encouraging and adopting 
cervical screening programmes. 
The World Health Organization (WHO) 
recommends that women should start screening 
for cervical cancer at 30 years or above, and include 
younger women only when the higher-risk groups 
have been covered. If a woman can be screened only 
once in her lifetime, then the best age is between 
35 and 45 years. In 25–49 year olds, a three-year 
screening interval should be considered if resources 
are available. For women over 50 years, a five-year 
interval is appropriate, but for those over 65, it is 
not deemed necessary provided the two previous 
smears were negative.2 The incidence of cervical 
cancer in the UAE would significantly decrease 
if we were to adopt such an effective screening 
programme.
There is a shortage of studies in the Arabian Gulf 
region on the rates and results of Pap smear testing. 
The present study addresses this issue with the aim 
of estimating the proportion of women undergoing 
Pap smear examinations and the frequency of 
epithelial cell abnormalities in a teaching hospital 
in an emirate of the UAE during a three year period. 
Advances in Knowledge
- This paper contributes to assessing current levels of cervical screening in the United Arab Emirates (UAE). The rate of opportunistic 
screening with Papanicolaou smear was only 0.4% in women attending the Obstetrics & Gynaecology Department of a teaching hospital 
in the UAE.
- The overall frequency of cervical intraepithelial abnormalities was 3.3%, out of which 1.8% had atypical squamous cells of undetermined 
significance (ASCUS), 1.2% had low-grade squamous intraepithelial lesion (LSILs), and 0.3% had high-grade squamous intraepithelial 
lesions (HSILs). 
Application to Patient Care
- The proportion of women who underwent an opportunistic Pap smear was very low. This indicates a major problem of missed 
opportunities for actively offering Pap smear testing. 
- Educational efforts can be targeted toward gynaecologists, nurses, and other health care workers to play an active role in educating 
patients on the importance of Pap smear testing, and to offer it whenever possible. 
- Community health awareness campaigns on the importance of cervical screening are recommended for women in the reproductive age 
group.                   
- Organised, cost-effective cervical screening can be introduced to encourage more women to undergo Pap smear testing.
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Methods
A record-based study was conducted at the 
Gulf Medical College Hospital and Research 
Center (GMCHRC) in Ajman, UAE. GMCHRC 
is a teaching hospital that caters not only to the 
patients of the Emirate of Ajman, whose adult 
female population is ~88,000, but also attracts 
patients from the neighbouring emirates because 
of its subsidised rates.8 Access to the Obstetrics 
& Gynaecology Clinic is by self-presentation. The 
clinic actively offers Pap smear screening at the cost 
of ~$100 per test.
The Cytology Unit of the Histo/Cyto-
Pathology Laboratory of GMCHRC is run by three 
pathologists and one cytotechnologist. ThinPrep 
liquid-based cytology was the method used for the 
collection and preparation of all Pap smear test 
samples. All three pathologists were involved in 
interpreting the Pap smear tests results with each 
slide double-checked by two different pathologists 
to verify the results. No mismatch was recorded 
during the verification of the results of this study. 
Specimen adequacy and reporting was done 
according to the revised Bethesda System 2001.9
The study sample included a series of Pap 
smears taken from women attending the Obstetrics 
& Gynaecology Clinic between July 2007 and July 
2010. The information was entered in a proforma 
designed specifically for this study. Variables 
selected for the study included abnormalities in the 
Pap smear, age, ethnicity, and menopausal status. 
Data were analysed using the Statistical Package for 
the Social Sciences, Inc. (SPSS), Version 19, (IBM, 
Chicago, Illinois, USA). Tables and graphs were 
created using SPSS, Microsoft (MS) Excel, and MS 
Word. Data were presented mainly as percentages 
and, to verify associations, the chi-square test was 
used.
All specimens with epithelial cell abnormalities 
were referred back to the Obstetrics & 
Gynaecology Department for further follow-
up. This follow-up was done according to the 
2001 Consensus Guidelines for Management of 
Women with Cervical Cytological Abnormalities, 
which recommends repeat cervical cytology, 
colposcopy, and human papilloma virus (HPV) 
testing for patients with atypical squamous cells of 
undetermined significance (ASCUS).10 
Results
The total number of outpatients who attended 
the GMCHRC Obstetrics & Gynaecology Clinic 
from July 2007 to July 2010 was 150,111, of which 
632 underwent a Pap smear test. Therefore the 
proportion of women who underwent this screening 
test at GMCHRC was 0.4%. Further analysis was 
done on 602 reports as 30 (4.9%) reports had to 
be excluded from the study due to inadequate or 
hypo-cellular smears. The age range of the women 
who underwent the Pap smear test was 20–71 years 
(mean ± standard deviation (SD) = 37 ± 9). Arabs 
constituted 50.1% of the study sample and 49.9% 
were from Asian and other countries [Figure 1].
Of the 602 women who had a Pap smear, 73% 
had specific complaints such as itching, vaginal 
discharge, pain, menorrhagia, and post-coital 
bleeding. The remaining 27% were asymptomatic 
and came for a routine screening. Post-coital 














134 (25) 29 (41) 163 (27)
Menorrhagia 33 (6) 4 (6) 37 (6)
Vaginal 
discharge
152 (29) 13 (18) 165 (27)
Post-coital 
bleeding
102 (19) 6 (8) 108 (18)
Itching 21 (4) 6 (8) 27 (4)
Abdominal pain 43 (8) 6 (8) 49 (8)
Others 46 (9) 7 (10) 53 (9)
Total  531 (100) 71 (100) 602 (100)



















15 (2.8) 5 (7) 20 (3.3)
Total 531 (100) 71 (100) 602 (100)
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bleeding and discharge were the most common 
symptoms in non-menopausal women when 
compared to menopausal women, as seen in Table 
1. 
Table 2 shows the results were positive for 
intraepithelial lesions in 3.3% of the total of 602 
samples. Intraepithelial lesions occurred in 7% of 
the menopausal and 2.8% of the non-menopausal 
women. The median age of patients with positive 
intra-epithelial lesions was 40 years with an age 
range of 24–56 years.
Figure 2 shows that out of the 20 samples positive 
for intra-epithelial lesions, 55% were ASCUS, 35% 
were low-grade squamous intraepithelial lesions 
(LSILs), and 10% were high-grade intraepithelial 
lesions (HSIL). Out of the 602 samples, ASCUS 
represented 1.8% of the total; LSIL 1.2%, and HSIL 
0.3%.
Discussion
In this study, the proportion of women who 
underwent an opportunistic Pap smear was very 
low. The rate of opportunistic screening with 
Papanicolaou smear was only 0.4%. The overall 
frequency of cervical intraepithelial abnormalities 
was 3.3%, out of which 1.8% had atypical squamous 
cells of undetermined significance (ASCUS), 1.2% 
had low-grade squamous intraepithelial lesion 
(LSILs), and 0.3% had high-grade squamous 
intraepithelial lesions (HSILs). 
Many reports have shown that mortality from 
cervical cancer occurs primarily in developing 
countries, reflecting the grim reality of the lack 
of effective control measures in the developing 
world.5,11,12 The high rate of incidence in these 
countries is mainly due to the lack of screening 
programmes, or their inefficacy.9 In this study, 
it was important to determine first the rates 
of opportunistic screening in the UAE, where 
organised cervical screening programs are not in 
place, and second to assess the proportion of Pap 
smears with epithelial cell abnormalities.          
The fact that merely 0.4% of the women 
underwent Pap smear testing is worrisome because 
cervical dysplasia is an asymptomatic ongoing 
change in the cervical epithelium. It can go 
unnoticed for many years and progress to cancer. 
If a woman presents to the clinic only when she has 
a gynaecological problem and regular Pap smears 
have not been done, the disease can easily take 
its natural course to full-blown cancer. The low 
number of Pap smear tests in our study could be 
attributed to a lack of patient awareness, absence 
of a nationwide screening programme, or a lack of 
initiative from many of the insurance companies to 
cover Pap smear testing in their basic packages. The 
latter results in patients having to pay for their own 
tests. 
There is a shortage of studies from the region 
regarding the practice of cervical screening. 
One study, done in Kuwait among 300 married 
Kuwaiti women, showed that only 23.8% of women 
underwent Pap smear testing, and the main reason 
given among the rest of the women for not having 
























Nationality of the study subjects (N = 602) 
 
Figure 1: Percentage distribution and number of subjects of the study according to location.
UAE = United Arab Emirates.
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Another study in Qatar among 500 women showed 
that almost 40% of women had had a Pap smear test 
at least once in their lifetime and the rest of them 
mentioned that they would have undergone the test 
if they were told that the procedure was painless 
and simple.14
In this context, educational efforts should be 
targeted toward gynaecologists, nurses, and other 
health care workers to encourage them to play 
an active role in educating the patients on the 
importance of Pap smear testing and its convenience, 
and to offer this test whenever possible. 
Research regarding risk factors and likelihoods of 
different minorities to develop invasive carcinoma 
has been studied extensively in Western countries; 
however, few studies have been performed in 
the Arabian Gulf region to assess the effects of 
dysplasia on the development of carcinoma. Studies 
regarding cervical dysplasia in the region show that 
the percentage of abnormal Pap smears was 4.7% in 
a prospective study in Saudi Arabia, much higher 
than the 1.6% reported in the compounded literature 
by Altaf.15 A 13-year study in Kuwait examined the 
incidence of squamous cells abnormalities at one 
tertiary hospital. The results indicated that there 
was an increasing trend in younger women toward 
developing LSILs and HSILs. From these results 
it was determined that screening programmes for 
young women in Kuwait is essential to preventing 
the disease.16 While the incidence of cervical cancer 
is generally low in the Arab world, it is the third 
most common cancer in women in the UAE.3 No 
published literature is available about the prevalence 
of cervical abnormalities in the northern emirates of 
the UAE, the place where this study was performed.
In our study, no cases of squamous cell 
carcinoma were detected and only 3.3% of the 
total cases were positive for intraepithelial lesions. 
This relatively low prevalence is similar to that 
reported in other studies done in the region. The 
reported prevalence was as follow: 4.3% in a tertiary 
hospital in Kuwait,16 5% in a large referral hospital 
in Saudi Arabia,17 1.66% in the western region of 
Saudi Arabia,18 7.9% in southwestern Saudi Arabia, 
and 4.5% in a study in the eastern Saudi Arabia.19 
A similar study done by the Faculty of Medicine 
& Health Science at UAE University reported the 
prevalence of cervical abnormalities in the UAE as 
1.32%, and no cases of squamous cell carcinoma out 
of the total 2,013 smears were detected.20
The fact that only 20 out of the 602 women 
had cervical epithelial abnormalities, given that 
108 women came with symptoms of post-coital 
bleeding, can be attributed to the fact that most 
of the those cases of post-coital bleeding could be 
due to other causes such as the use of intrauterine 
contraceptive device and cervicovaginal infections.
Conclusion
Voluntary routine screenings with Pap smears was 
remarkably low in this study group. ASCUS was the 
most common epithelial cell abnormality detected. 
Community health education and opportunistic 
screening for cervical cancer is recommended for 
both nationals and expatriate women in the region. 
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